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Tissue engineering is a promising new method for organ regeneration. This method can
be used to repair damaged tissue, or possibly replace a fully functional organ. In summary, a
biopsy is taken from a donor, isolated, then grown onto a framework resembling an organ. Once
grown; it is then transplanted into the patient. Over time, the body will degrade the scaffold,
leaving the organ or tissue in its place. As this scaffold is present in the body for an extended
time; factors like biocompatibility, toxicity, immunogenicity, and structural stability must be
researched.
Several polymers have already been researched for use in tissue engineering. However,
one in particular, Poly(lactic acid) or PLA, has taken notice as this has been proven effective in
current bone fixation procedures. Some medical devices like screws, pins, rods, meshes and
plates already use this material and is approved by the FDA. The reason PLA is used is it
degrades into lactic acid, an already present chemical byproduct found in the human body which
will not stimulate a negative immune response. Current research shows several studies involving
the use of osteoblasts but information on other cell types are extremely limited.

This thesis aims to investigate if cellular adherence is possible on this hydrophobic
polymer using several different methods and three-dimensional printing orientations. H4iie cells
were cultured on six acid-catalyzed PLA scaffolds for four days. Each scaffold was either
uncoated or coated with extracellular matrices Matrigel or Collagen IV. Cellular attachment was
then quantified and compared to the control group.
Results show cellular attachment was possible on an untreated surface. However, due to
the hydrophobicity of the polymer, a protein substrate with a vertically printed surface enhanced
cellular attachment. As this material is currently being used in medical procedures, PLA may be
a suitable, nontoxic material that has great potential for further research in tissue engineering.
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INTRODUCTION

Overview
Tissue engineering is a fairly new advancement in biomedical science. Typical
procedures focus on extracting a biopsy from either a compatible donor or an individual’s own
cells. These are then grown and cultured in a monolayer using a tissue culture flask or petri dish.
Cells are then expanded using several growth factors to enhance cellular proliferation. This is
because primary cells are terminally differentiated. Grown cells are then transferred and cultured
onto a three-dimensional scaffold that is made out of a biocompatible polymer that acts as a
framework for cells to adhere to and proliferate around. Once a fully functional organ is created,
it is then transferred into the patient’s body. Refer to Figure 1 for a simplified diagram
explaining this procedure.

Figure 1: Tissue Culture Engineering Diagram (Ude, 2018)
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Several factors must be considered and researched before developing a scaffold in tissue
engineering. First and foremost, the scaffolding must be made of a biocompatible and nontoxic
material that can sustain this for long term exposures. Cells must be able to adhere and function
normally on the polymer surface and throughout the entirety of the scaffold. Cells must also be
able to function normally, grow, proliferate and repair themselves before and after implantation
without eliciting a negative immune system response. These scaffolds must also be degradable
and its products must not elicit a negative immune response. Scaffolds should also have a high
porosity and an interconnected pore structure that ensures cells are adequately supplied with
nutrients (O’Brien, 2011).

Several different materials and polymers have already been investigated in the field of
tissue engineering. Some polymers that have already been approved by the FDA are Poly(lactic
acid), poly(glycolic acid), and poly(caprolactone). Poly(caprolactone) or PCL is a rubbery type
polymer that loses its integrity after several years. This is especially not suitable for tissue
regeneration as this can be harmful for long term exposures. Poly(glycolic acid) is another
polymer used in various clinical applications. However, the lifespan of this material in the
human body is very short lived. PGA is typically broken down in as little as one month. PLA is
an ideal polymer as this can be broken down in as few as a couple months to a year, refer to
Figure 2. This degradation may be due to its hydrophobicity. Poly(lactic acid), or PLA, is a
“biocompatible, biodegradable, and immunologically inert synthetic polymer” (Tagle, 2010). It
is an extremely hydrophobic material compared to that of PGA which makes this polymer more
suitable for tissue engineering.

2

Figure 2: Adsorption Comparison (Ikada, 2006)

Poly(lactic acid) has already been approved by the Federal Drug Administration (FDA)
for use in various wound management and bone fixation applications, which makes this ideal as
this has been deemed healthy from the FDA and the legwork in terms of testing and procedures
has already been completed. Current medical procedures and devices that currently use PLA are
sutures, stents, screws, pins, and grafts. As this polymer breaks down, it degrades into lactic acid,
an already present chemical by product found in red blood and muscular cells in the human
body. Due to this, this material is a great option since it will not stimulate a negative immune
response.

Hydrophobicity
PLA is a hydrophobic polymer that can affect cellular adherence. As there is a carbonyl
group and methyl group located on the chain, refer to Figure 3 for a molecular diagram of PLA.
There is a lack of reactive side-chain groups the make this polymer inert. This inertness prevents
the polymer from reacting with water (Baran, 2019). Because of this hydrophobicity, several
cell lines may have difficulty in adhering to the surface of a scaffold.
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Figure 3: Poly(Lactic Acid) Molecule, (polysciences.com)

Degradation
One of the major contributors to this degradation reaction is hydrolysis. In the presence
of water, the diffusion of water into the polymer hydrolytically cleaves the ester groups located
on the main chain, refer to Figure 4 for a simplified degradation reaction of PLA. This then
forms water soluble compounds that make it easier for metabolic clearance.

Figure 4: Degradation Reaction
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Temperature and the pH of the hydrolytic degradation can also significantly increase or
decrease the clearance time at which the body degrades the polymer. Temperature can have a
significant effect on the hydrolytic degradation of PLA, especially at higher temperatures.
However, at body temperature the clearance constant can be estimated close to one hundred
thousand times slower than that of 220 °C which is very slow, refer to Figure 5. To determine
this constant, Gorrasi used a modified derivation of the Arrhenius equation with an Activation
Energy of 10000 K. As this is an extremely high activation energy, this is the cause of the
kinetic constant being so low as shown in Figure 5.

Figure 5: Temperature Degradation (Gorrasi, 2013)

Another factor that should be considered is the pH of the area the transplant will take
place. Depending on the area, pH can vary significantly, refer to Figure 6. For reference,
stomach acid is highly acidic with a pH of around 1 to 2 and the pH of blood is somewhere in the
middle of basic and acidic at around 7.4-7.6 (Gorrasi, 2013). Refer to Figure 6 to see the
normalized kinetic constant calculated by Gorrasi. In essence the kinetic constant is highly
5

dependent on the pH of the system. This data can assist in determining the degradation of PLA
in certain areas of the body. Transplanting a newly functional organ into areas of the body that is
very acidic, or in areas with a pH greater than 5 is optimal.

Figure 6: pH Degradation (Gorrasi, 2013)

Protein Substrates

To enhance cellular attachment, protein substrates are typically used in cell culture
practices as an attachment factor. “Attachment factors are structural proteins or protein-like
substances that have adherent capabilities and increase cell-substrate interactions in a culture
dependent attachment milieu. A number of glycoproteins have been identified that promote
and/or influence in-vitro cell attachment to the surface or substratum of the culture vessel.
Normal attachment, growth and development of many cell types are dependent on attachment
factors and extracellular matrix (ECM) components. While some cells are able to synthesize
these components, others require an exogenous source” (Biological Industries).
6

Collagen I, Rat Tail is a fibrous protein abundant in connective tissues such as the
tendon, ligament, dermis, and blood vessels. It is the major component and the primary
determinant of tensile strength of the extracellular matrix (ScienCell). Another protein substrate
that is commonly used in cellular attachment is matrigel, or commonly known as basement
membrane extracellular matrix. Matrigel is a combination of extracellular proteins and growth
factors like collagen, laminin, and gelatin (Corning). This proprietary concoction of extracellular
matrix proteins makes it a suitable candidate for cellular attachment as this will provided the
most diverse conditions for cellular attachment.

Porosity

Porosity of a 3-dimensionally printed culture vessel can also have a major impact on
cellular attachment. The porosity or void fraction of the scaffold must be small enough to
facilitate mechanical interlocking between the cellular tissue and the three dimensional scaffold.
Porosity must be able to provide a structurally stable support for the weight of the tissue as well
as be large enough to effectively transport cellular waste as well as biofactors like proteins,
genes, and nutrients for cell growth. Pores should also provide enough room for vascularization
or blood flow to develop. The difficulty in developing a scaffold is to develop a balance between
the mechanical and mass transport function of the scaffolding system (Loh, 2013).

Three-Dimensional Printing

Three-dimensional printing orientation can create variable pores and channels. For the
sake of this thesis, square three-dimensional scaffolds were printed with the following
dimensions (35.4 mm x 35.4 mm x 2 mm). Refer to Figure 7 for an image displaying one printed
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layer out of several hundred layers. Scaffolds printed in a horizontal orientation are printed from
the outer most edges first then closer towards the center is a very porous and lattice structure. If
looking at the scaffold from above and into one pore, the ability to see through is not possible.
This is because each layer is not consistent with the layer below, leaving variable pore and
channels. Another way to think about it is that the outer edges are very smooth and solid, while
the center of the scaffold consists of a lattice pattern leaving larger pores. Scaffolds printed in a
vertical orientation are printed in the same fashion except these are taller and printed vertically
rather than horizontally. Outer most edges are printed first, and these are not porous and very
smooth, but the center area consists of a lattice pattern leaving very small pores in the center.
With the vertically printed scaffolds, cells will have a difficult time entering the scaffold as the
outer most surfaces provide little to no porosity.

Figure 7: 3D Printing Protocol

Chemical Engineering Concepts

Current biological research has only recently started to explore using PLA for tissue
engineering. As this is still in its infancy, research has been tailored to known practices like
8

bone tissue replacement procedures. Using chemical engineering principles, developing a cheap
polymer like PLA for use in tissue engineering used the knowledge of mass transport, chemical
kinetics of nutrients and polymers found in Organic Chemistry.

Gaps in Research
Poly(lactic acid) is easily decomposed in the body, leaving a void in its place. Current
procedures use this polymer for bone screws, pins and devices that can easily decompose as the
bone heals itself. However, there is a huge lack of available research using PLA with other cell
types.
Experimental Objectives
1) Determine if a mammalian cell line can adhere on an untreated acid-catalyzed Poly(lactic
acid) scaffold.
2) Determine if the same cell line can adhere on a protein substrate coated Poly(lactic acid)
scaffold.
3) Determine if the printing orientation of the scaffold affects cellular adherence.
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PRELIMINARY EXPERIMENTS AND RESULTS
Preliminary research was performed by a fellow graduate student, Piao Jian Tan. In his
procedure, Human Embryonic Kidney, HEK-293, cells were cultured in 100 mm petri dishes and
maintained in a 37 °C, 5% CO2, humidified incubator with complete growth medium consisting
of 90% Eagle’s Minimum Essential Medium, 10% Fetal Bovine Serum and a 1%, 100x stock of
Penicillin/streptomycin. Fresh medium was replaced every two to three days and cells were
subcultured as needed in sterile petri dishes. Cells were then seeded onto square, acid-catalyzed
Poly(lactic acid) scaffolds (35.4 mm x 35.4 mm x 4 mm) into glass 60 mm petri dishes. Post
seeding, fresh medium was replaced every day as well as imaging, refer to Figure 8. Due to the
thickness and opaqueness of the scaffold, visualization of cells was extremely difficult. After
seven days in culture, a Hematoxylin and Eosin, H&E, stain was used to stain the cells for better
visualization on the topmost portion of the scaffold.
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B

D

E

C

Figure 8: Preliminary Images, HEK-293 Cells (Tan, 2019)

Image A shows HEK-293 cells growing under normal conditions in a glass petri dish.
Image B displays the topmost corner of the horizontal scaffold with HEK-293 cells attached to
the petri dish. Image C is a higher resolution image of Image B. Image D displays one pore on
the topmost section of the horizontally printed scaffold after the H&E stain. Dark spots indicate
the cell nucleus. Image E shows the topmost corner of the horizontally printed scaffold after the
H&E stain. Dark spots indicate cell nuclei. It was indicated from Piao Jian Tan, that cells were
indeed attached to the topmost surface.
Preliminary images display that cellular attachment using this protocol is indeed possible.
However, there was very limited cellular attachment across the entirety of the topmost surface.
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Cells that did adhere were very sparse, separated and a higher concentration of cells tended to
migrate, adhere and grow along the corners and edges of the scaffold.
As HEK-293 cells can be cultured in both monolayer and suspension conditions, this cell
line is loosely adherent and should be changed. Upon taking leadership of this project another
cell line was researched to determine if another cell line would enhance cellular attachment. It
was determined to use H4iie cells. H4iie cells are a cheap, robust, and strongly adherent
epithelial cell line derived from Rat liver, Rattus Norvegicus. This particular cell line is
traditionally used in several in vitro cytotoxicity models to closely mimic human liver toxicity.
They are an extremely robust cell line that has strong resistances and a doubling time of
approximately “22-24 hours” (Yang, 2011) while HEK-293 cells can be grown in suspension or
by attachment with a doubling time of “34 hours” (Cervera, 2011). Another minor consideration
is that HEK-293 cells are derived from Human Embryonic Kidney’s. As these are an embryonic
cell line, this can be viewed as controversial.
H4iie cells were cultured and maintained in 150 cm2 tissue culture flasks, (CytoOne,
Cat# CC7682-4815) using a complete growth medium consisting of 90% Minimum Essential
Medium (Gibco, Cat#: 11095-080, Lot: 2152915) and 10% Fetal Bovine Serum (Gibco, Cat#:
26140079, Lot: 1645615) in a 37 °C, 5% CO2 humidified incubator. Prior to seeding, Poly(lactic
acid) scaffolds were soaked in 70% ethanol for thirty minutes then sterilized under ultraviolet
light for another 30 minutes. Then, 100 mm petri dishes were coated with a basement layer of
1% Agar, Cells were then seeded at a density of five million cells onto vertically printed square
Poly(lactic acid) scaffolds in 100 mm petri dishes. Media was gently changed every day for four
days. Pictures were taken daily using a 4X inverted microscope, refer to Figure 9.
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Figure 9: Preliminary Images, H4iiE Cells

Image A is a picture taken of the uncoated vertically printed scaffold post seeding. Image
B is a picture taken of an uncoated, vertically printed scaffold one day after seeding. Image C is
a picture taken of the uncoated, vertically printed scaffold three days after seeding. Image C is a
picture taken of the uncoated, vertically printed scaffold four days after seeding. No
distinguishable cell bodies were displayed in Images A, B or C. However, Image D displays
small cell colonies of H4iie cells attached to the uncoated, vertically printed PLA scaffold. After
accounting for the doubling time, these are not the ideal conditions for cellular adherence.
However, these results show that cellular adherence is indeed possible; but this may be enhanced
by using a protein substrate. Another variable that may enhance cellular attachment is the
printing orientation of the scaffold.
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METHODS
Three-Dimensional Scaffold Printing Procedure
Scaffolds were printed with the following dimensions, 35.4 mm x 35.4 mm x 2 mm.
Scaffolds were printed at 220 °C, a 60 °C plate temperature and a 100 % infill. Once the
scaffold was printed, the surfaces were polished with grinding papers of grade 600, 1200-fine
then with a 1-micron grade containing alumina. After polishing, the scaffolds were washed with
deionized water then 70% ethanol and air dried for 5 hours. Scaffolds were then sterilized for
10 minutes under an ultraviolet light (UV) before being soaked in deionized water. Then
sterilization continued with being heated in a 130 °C oven for 30 minutes. To treat the surface,
scaffolds were treated using an acid-catalyzed reaction by soaking in a 1 M sodium hydroxide
and ethanol solution for 6 hours. After soaking, scaffolds were washed with deionized water
thoroughly and vacuumed for 6 hours.
Cell Culture and Initial Procedure
H4iie cells (ATCC, Cat#: CRL-1548, Passage 30) were cultured and maintained in
150 cm2 tissue culture flasks, (CytoOne, Cat# CC7682-4815) using a complete growth medium
consisting of a 90% Minimum Essential Medium (Gibco, Cat#: 11095-080, Lot: 2152915) and
10% Fetal Bovine Serum (Gibco, Cat#: 26140079, Lot: 1645615) in a 37 °C, 5% CO2
humidified incubator. Prior to seeding, Poly(lactic acid) scaffolds were soaked in 70% ethanol
for thirty minutes then sterilized under ultraviolet light for another 30 minutes. Scaffolds were
placed into a petri dish coated in a basolateral layer of 1% wt/vol Agar using the following
experimental conditions, refer to Table 1. Only one replicate was performed for each
experimental condition.
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Table 1: Experimental Conditions

Vertical
Horizontal

No
substrate
1 scaffold
1 scaffold

Matrigel
(0.25 mg/mL)
1 scaffold
1 scaffold

Collagen I
(50 µg/mL)
1 scaffold
1 scaffold

Collagen I, Rat Tail Coating Procedure
Collagen I, Rat Tail was purchased from Gibco (Cat#: A10483-01, Lot#: 2103638, Exp:
2020-07-03, Storage: 4 °C, Concentration: 3 mg/mL). It was recommended from the supplier
that a desired concentration of 50 µg/mL be used to coat the surface. To ensure enough substrate
was used to entirely submerge the scaffold, 5 mL of substrate was made for each scaffold.
𝐶𝑆𝑡𝑜𝑐𝑘 𝑉𝐼𝑛𝑖𝑡𝑖𝑎𝑙 = 𝐶𝐹𝑖𝑛𝑎𝑙 𝑉𝐹𝑖𝑛𝑎𝑙

𝑉𝐹𝑖𝑛𝑎𝑙,𝐶𝑜𝑙𝑙𝑎𝑔𝑒𝑛

µ𝑔
𝑚𝐿
𝐶𝑆𝑡𝑜𝑐𝑘 𝑉𝐼𝑛𝑖𝑡𝑖𝑎𝑙 50 𝑚𝐿 ∗ 5 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 ∗ 2 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑
=
=
= 0.1667 𝑚𝐿
𝑚𝑔
µ𝑔
𝐶𝐹𝑖𝑛𝑎𝑙
3 𝑚𝐿 ∗ 1000 𝑚𝑔

𝑉20 𝑚𝑀 𝐴𝑐𝑒𝑡𝑖𝑐 𝐴𝑐𝑖𝑑 𝑖𝑛 𝑃𝐵𝑆 = (5

𝑚𝐿
∗ 2 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑) − 0.1667 𝑚𝐿 = 9.833 𝑚𝐿
𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑

Equation 1: Collagen Formulation Calculations

The collagen solution was prepared on ice by transferring 166.7 µL of Collagen IV to a cold
15 mL conical containing 9.833 mL of ice cold, 20 mM Acetic Acid, refer to Equation 1 for
calculations. Each scaffold was submerged into 5 mL of prepared substrate and incubated at
room temperature for 1 hour. The solution was then removed using an aspirator connected to a
vacuum and the scaffolds were allowed to air dry before use.
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Matrigel Coating Procedure
Matrigel, or basement membrane ECM was purchased from Corning (Cat# 354277, Lot#:
354277, Storage: -80 °C, Concentration: 10 mg/mL). From previous experiences, typical
concentrations of matrigel for primary hepatocytes was 0.25 mg/mL. To ensure enough
substrate was used to entirely submerge the scaffold 5 mL of substrate in complete growth media
was made for each scaffold.
𝐶𝑆𝑡𝑜𝑐𝑘 𝑉𝐼𝑛𝑖𝑡𝑖𝑎𝑙 = 𝐶𝐹𝑖𝑛𝑎𝑙 𝑉𝐹𝑖𝑛𝑎𝑙

𝑉𝐹𝑖𝑛𝑎𝑙,𝑀𝑎𝑡𝑟𝑖𝑔𝑒𝑙

𝑚𝑔
𝑚𝐿
𝐶𝑆𝑡𝑜𝑐𝑘 𝑉𝐼𝑛𝑖𝑡𝑖𝑎𝑙 0.25 𝑚𝐿 ∗ 5 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 ∗ 2 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑
=
=
= 0.25 𝑚𝐿
𝑚𝑔
𝐶𝐹𝑖𝑛𝑎𝑙
10 𝑚𝐿

𝑉𝑀𝑒𝑑𝑖𝑎 = (5

𝑚𝐿
∗ 2 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑) − 0.25 𝑚𝐿 = 9.75 𝑚𝐿
𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑

Equation 2: Matrigel Formulation Calculations

The matrigel solution was thawed overnight at 4 °C in an ice bath. As this a thermo-sensitive
gel, once this is exposed to heat the proteins will polymerize and solidify. Once thawed, 250 µL
of matrigel was transferred to an ice cold 50 mL conical containing 9.75 mL of ice-cold media
using ice-cold pipet tips, refer to Equation 2 for calculations. Each scaffold was submerged into
5 mL of prepared substrate then immediately placed in a 37°C, humidified incubator overnight.
Agar Gelling Procedure
As agar is commonly used in microbiological culture and its ability to solidify and form
as a hydrogel, this was used to hold the scaffold in place. To do this, agar powder was purchased
on Amazon and manufactured by Now Real Food. A 1% wt./vol agar solution was prepared by
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adding 5 grams of agar powder to 500 mL of deionized water in a glass autoclavable jar.
Solution was whisked and mixed thoroughly before being heat treated and sterilized in a 121 °C
autoclave for 25 minutes. Once the container was touchable with gloved hands, 20 mL of
warmed agar was transferred to each 100 mm petri dish in a sterile Biosafety Cabinet. Once the
agar solution began solidifying, each scaffold was immediately pressed into the hydrogel,
exposing the topmost surface. Scaffolds and agar were allowed to rest at room temperature for
30 minutes in a biosafety cabinet until the solution solidified.
Cell Seeding Procedure
Media was removed from the tissue culture flask using an aspirator connected to a
vacuum. H4iie cells were then washed with 15 mL of Phosphate Buffered Saline (PBS). PBS
was removed using an aspirator and 4 mL of TrypLE (Gibco, Cat#: 1253011) was transferred to
the flask using a serological pipette. The cell culture flask was incubated at 37°C for
approximately 5 minutes until cells detached from the surface. 5 mL of warmed complete
growth medium was added to the flask to neutralize the enzymatic digestion. The entire volume
of cell suspension was transferred to a 15 mL centrifuge tube and centrifuged at 200xG for
8 minutes. Supernatant was removed by aspiration and the cell pellet was resuspended in 10 mL
of fresh complete growth medium. 25 µL of cell suspension was immediately transferred to a
1.5 mL Eppendorf containing 25 µL of Trypan Blue (Hyclone, Cat#: SV30084.01). 10 µL of
trypan blue cell suspension was transferred to each compartment on an automated cell counter
slide. Cells were then counted using a Countess II automated cell counter, refer to Table 2 for
direct output from the cell counter. In the left column, this is this direct output calculated using
the automated cell counter. However, the cell counter does not consider the total volume of the
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cell suspension. Since the total volume of the cell suspension was 10 mL, the left column was
multiplied by 10 mL to obtain the Total Number of cells.
Table 2: Initial Cell Counts

Count 1
Count 2
Average

Cells/mL
4.16 (106)
3.85 (106)
4.01 (106)

Total Cells
4.16 (107)
3.85 (107)
4.01 (107)

Cells were then seeded onto each scaffold at a seeding density of five million cells per scaffold
in 5 mL of complete growth medium.
𝑐𝑒𝑙𝑙𝑠
∗ 6 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑𝑠
𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑
∗ 10 𝑚𝐿 = 7.5 𝑚𝐿
40050000 𝑐𝑒𝑙𝑙𝑠

5000000
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝐶𝑒𝑙𝑙 𝑆𝑢𝑠𝑝𝑒𝑛𝑠𝑖𝑜𝑛 =

𝑀𝑒𝑑𝑖𝑎 𝑁𝑒𝑒𝑑𝑒𝑑 = (5

𝑚𝐿
∗ 6 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑) − 7.5 𝑚𝐿 = 22.5 𝑚𝐿
𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑

Equation 3: Cell Seeding Calculations

7.5 mL of cell suspension was transferred to a sterile 50 mL centrifuge tube containing 22.5 mL
of fresh complete growth medium. This was inverted several times then 5 mL of this cell
suspension was transferred to each petri dish containing a scaffold. Each scaffold was incubated
in a 37 ’C incubator for one hour to allow cells to settle and attach before an additional 15 mL of
fresh medium was added to each dish to completely cover the surrounding surface.
Maintenance Procedure
Each scaffold was cultured in a 37 °C, 5% CO2 humidified incubator. To maintain
healthy cells nutrients 20 mL of fresh media replacement every day. This not only adds nutrients

18

to keep cells healthy, but this also removes any residual waste byproducts released from the
cells.
Take Down Procedure
On Day 4, some scaffolds began lifting out of the agar gelatin. So, initiation of the take
down procedure was started. Scaffolds were removed from their culture dish and transferred to a
new petri dish. 3 mL of warmed TrypLE was added to each scaffold and these were allowed to
incubate in a 37 °C, 5% CO2 incubator for 5 minutes. Using a 1 mL pipette, the TrypLE was
gently agitated on the scaffold to ensure adequate cellular detachment. Then, 5 mL of warmed
complete growth medium was added to each petri dish to neutralize the enzymatic digestion.
Each scaffold was then agitated using a serological pipette 3 times. The entire contents of each
dish were then transferred to a separate 15 mL centrifuge tube and centrifuged at 200xG for
8 minutes. Supernatant was then removed using an aspirator connected to a vacuum, and the cell
pellets were resuspended 5 mL of fresh complete growth medium. 25 µL of cell suspension was
immediately transferred to a 1.5 mL Eppendorf containing 25 µL of Trypan Blue (Hyclone,
Cat#: SV30084.01). 10 µL of the trypan blue cell suspension was transferred to each
compartment on an automated cell counter slide. Cells were then counted using a Countess II
automated cell counter and compared to their respective control group.
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RESULTS
In this section, images were taken daily of each scaffold under a 4x inverted microscope.
Several images were taken, and the best quality images were chosen to represent each
experimental condition.
DAY 0

DAY 2

DAY 3

DAY 4

Figure 10: Horizontal Control Images

Refer to Figure 10 for images related to the uncoated horizontally printed scaffold. There
are no distinguishable cell bodies visible in these photos. From these photos it is not clear what
resides in each pore. However, it may be residual Agar being pushed into the scaffold during the
setting process.
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DAY 0

DAY 2

DAY 3

DAY 4

Figure 11: Horizontal Collagen Images

Refer to Figure 11 for images related to the Collagen coated horizontally printed scaffold.
There are no distinguishable cell bodies visible in these photos. From these photos it is not clear
what resides in each pore. However, it may be residual Agar being pushed into the scaffold
during the setting process.
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DAY 0

DAY 2

DAY 3

DAY 4

Figure 12: Horizontal Matrigel Images

Refer to Figure 12 for images related to the Matrigel coated horizontally printed scaffold.
There are no distinguishable cell bodies visible in these photos. From these photos it is not clear
what resides in each pore. However, it may be residual Agar being pushed into the scaffold
during the setting process.
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DAY 0

DAY 2

DAY 3

DAY 4

Figure 13: Vertical Control Images

Refer to Figure 13 for images related to the uncoated, vertically printed scaffold. There
are no distinguishable cell bodies visible in these photos.
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DAY 0

DAY 2

DAY 3

DAY 4

Figure 14: Vertical Collagen Images

Refer to Figure 14 for images related to the Collagen coated, vertically printed scaffold.
Day 2 displays significant cell colonies and single cell structures attached to the surface of the
collagen coated, vertical scaffold. On day 3, the shadows are cell colonies attached on the inner
portion of the scaffold. On day 4, the image was extremely hazy as the scaffold lifted from the
agar. Thus, the poor visual quality.
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DAY 2

Figure 15: Vertical Collagen Image (Day 2)

Refer to Figure 15 for a larger image related to Day 2 of the Collagen coated, vertically
printed scaffold. In this image, several cell colonies and single cell structure outlines are visibly
attached to the scaffold surface. Cells tended to be very sparse through the entire top portion of
the surface and there is limited cell networking occurring.
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DAY 0

DAY 2

DAY 3

DAY 4

Figure 16: Vertical Matrigel Images

Refer to Figure 16 for images related to the Matrigel coated, vertically printed scaffold.
Days 2, 3 and 4 display significant cell colonies and single cell structures attached to the surface
of the matrigel coated, vertical scaffold.
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DAY 2

DAY 3

Figure 17: Vertical Collagen Image (Day 2)
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Refer to Figure 17 for a larger image related to Day 2 and 3 of the Matrigel coated,
vertically printed scaffold. In this image, several cell colonies and cellular networks are attached
to the scaffold surface.
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A

B

C

Figure 18: Vertical Matrigel Additional Images (Day 4)

Refer to Figure 18 for additional day 4 photos that were taken of the Matrigel coated,
vertical scaffold. Using a 10X, inverted microscope, Image A displays evenly spread, cell
colonies that have begun interconnecting and quite possibly forming an ECM. Image B is
another image of evenly spread cell colonies. Image C displays a corner most section of the
scaffold that does not display any cellular attachment.
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Table 3: Final Cell Count Results

Horizontal (Control)

Vertical (Control)

Cells/mL

Total Cells

Cells/mL

Total Cells

Count 1

0

0

Count 1

5860

29300

Count 2

35200

176000

Count 2

3520

176000

Std Dev

-

88000

Std Dev

-

73350

Average

17600

88000

Average

4690

102650

Horizontal (Collagen I)

Vertical (Collagen I)

Cells/mL

Total Cells

Cells/mL

Total Cells

Count 1

334000

1670000

Count 1

346000

1730000

Count 2

346000

1730000

Count 2

411000

2055000

Std Dev

-

30000

Std Dev

-

162500

Average

340000

1700000

Average

378500

1892500

Horizontal (Matrigel)

Vertical (Matrigel)

Cells/mL

Total Cells

Cells/mL

Total Cells

Count 1

5860

29300

Count 1

469000

2345000

Count 2

5860

29300

Count 2

575000

2875000

Std Dev

-

0

Std Dev

-

265000

Average

5860

29300

Average

522000

2610000

Cells were counted using a Countess II automated cell counter, refer to Table 3 for direct
output from the cell counter. In the left column, this is this direct output calculated using the
automated cell counter. However, the cell counter does not consider the total volume of the cell
suspension. Since the total volume of the cell suspension was 5 mL, the left column was
multiplied by 5 mL to obtain the Total Number of cells.
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Horizontal Scaffold
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1600000
1400000

Cell Count
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1000000
800000
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400000
200000
0
Collagen I

Matrigel

Control

Figure 19: Horizontally Printed Scaffold Results

Total cells calculated from Table 3 were graphed using a bar chart for each horizontally
printed experimental condition, refer to Figure 19. For the horizontally printed scaffolds,
Collagen I provided extremely higher cell counts compared to the matrigel and control groups.
Error bars are not provided as only one replicate was performed.
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Vertical Scaffold
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Cell Count
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500000

0
Collagen I

Matrigel

Control

Figure 20: Vertically Printed Scaffold Results

Total cells calculated from Table 3 were graphed using a bar chart for each vertically
printed experimental condition, refer to Figure 20. For the vertically printed scaffolds, Matrigel
provided the highest cell counts compared to the Collagen and control groups. However,
Collagen I provided similar results to the Matrigel coated scaffolds. Error bars are not provided
as only one replicate was performed.
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Horizontal Scaffold
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Cell Count (% of Control)

2000
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0
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Matrigel

Figure 21: Horizontally Printed Scaffold Results (% of Control)

Total cells calculated from Table 3 were compared to the horizontal control group using a
bar chart for each horizontally printed experimental condition, refer Figure 21. For the
horizontally printed scaffolds, Collagen I provided extremely higher cell counts compared to the
matrigel and control groups. Error bars are not provided as only one replicate was performed.
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Vertical Scaffold
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Cell Count (% of Control)
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Figure 22: Vertically Printed Scaffold Results (% of Control)

Total cells calculated from Table 3 were compared to the vertical control group using a
bar chart for each vertically printed experimental condition, refer to Figure 22. For the vertically
printed scaffolds, Matrigel provided the highest cell counts compared to the Collagen and control
groups. However, Collagen I provided similar results to the Matrigel coated scaffolds. Error
bars are not provided as only one replicate was performed.
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DISCUSSION AND FUTURE WORK
Experimental Objective One
From the results, each experimental objective was successfully completed. For
experimental objective one, cells did in fact adhere to the uncoated acid-catalyzed Poly(lactic
acid) scaffolds using both printing orientations. However, cellular adherence was very limited
and very negligible compared to the seeding density of five million cells. After four days and
taking doubling time into account this surface does not promote a surface suitable for cellular
adherence.
Experimental Objective Two
For experimental objective two, after introducing a protein substrate like collagen I, and
Matrigel, cellular adherence did increase by at least 1800% with the exception of the horizontally
printed scaffold coated with matrigel. Printing orientation significantly affected cellular
adherence especially with the vertically printed scaffolds. Both protein substrates promoted a
framework that increased cellular adherence compared to the control scaffold. For the horizontal
scaffold, collagen I increased cellular adherence compared to that of matrigel. From these
results, it is not very clear why this is the case, especially when the cellular adherence in the
vertical scaffolds were comparable. One factor could be that the concentration of matrigel was
just too low. Or the size of the proteins that are in matrigel are just too large to adhere to the
micro pore surface on the horizontal scaffolds. Matrigel consists of several different proteins,
especially Laminen and Collagen IV. Laminen is a fairly large, folded protein that is
approximately 400 to 900 kDa while Collagen IV is approximately 180 kDa. Laminen in
particular folds into a very large protein structure. This may be one of the contributing factors to
decreased cellular adherence.
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Experimental Objective Three
For experimental objective cellular adherence was significantly increased in the vertically
printed scaffolds. The outer most surface is very solid with a low void fraction. Protein
substrates can coat the entirety of the surface and provide more surface area for cells to adhere
to. But the void fraction is something that needs to be seriously considered as the horizontally
printed scaffolds could provide cells with the ability to supply nutrients and dispose of cellular
waste. From the results, horizontally printed scaffolds should be further researched using a
collagen substrate.
Future Work
In order to statistically verify these finding, this procedure should be repeated at a
minimum of three times. If these results are in fact repeatable, optimizing the protein substrate
concentrations for collagen should be investigated using a horizontally printed scaffold. Another
thing that should be adjusted in this protocol is to change the test performed during takedown.
Instead of lifting cells from the scaffold then counting, it would be more effective if another
method were used. I would recommend using a cellular proliferation assay provided from
CyQUANT (Cat#: C7026). This highly sensitive fluorometric assay works by assessing cellular
proliferation by dying nuclear DNA. Then the cells are lysed, and the DNA content is measured
using a fluorometric plate reader. Implementing this assay would reduce any inconsistencies
with lifting cells from the scaffold and performing cell counts. DNA content is relatively
consistent within each cell, this would allow this to be proportional to cell counting. Following
these studies, some toxicological testing should be done to investigate the toxicological effects of
cellular adherence using Poly(lactic acid) as a surface. Once, toxicological effects are
determined then primary human cells should be used.
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CONCLUSIONS
Tissue engineering is still in its infancy in terms of biomedicine. Only a few procedures
have been successfully performed (skin grafts, minor arteries, and a full trachea). However,
several organs have also been successfully grown. These procedures are especially expensive
and time consuming to perform. As more research is performed on tissue engineering using
inexpensive polymers, this can dramatically reduce the overall cost. Another impact tissue
engineering may provide is by using a patient’s own cells to manufacture a fully functional organ
this will dramatically decrease the need for organ and tissue donations all together. From the
contributions of this research, cellular attachment is indeed possible on Poly(lactic acid) surfaces.
Especially with a substrate coated surface. This may provide a very promising and inexpensive
polymer that deserves future research in tissue engineering.
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APPENDIX
LAB NOTEBOOK
In this appendix, scanned copies of laboratory notebook pages used during this thesis are
included.

41

42

43

44

45

46

